ARCHIVES

ODAC’s Dilemma: Proposed Indication Created By Reliance On PSA Screening and Hormonal Treatment

This article is from The Cancer Letter archive.

Vol. 37 No. 35 | September 23, 2011

Download PDF Visit The Full Archive

Related Articles

April issue of Business & Regulatory Report included (8 additional pages).

April 30, 2004

NCI Funds; Ad Hoc Group Approves NCCTG Renewal

September 18, 1981

Anna Barker Named Deputy Director for Strategic Scientific Initiatives

December 6, 2002

Study Finds No Benefit for Frequent CA125 Testing in Recurrent Ovarian Cancer

June 5, 2009

Senate Votes Down Attempt to Cut NCI Funds $100 Million

October 3, 1975

Cancer Incidence Rates Climb In HIV-Positive Female Populations

April 27, 2012